Physician
Oregon Oncology Specialists, LLP
Oregon Oncology Specialists, LLP was paid $3.50M by Medicaid between Jan 2018 and Dec 2024, across 35 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 36% of everything it billed.
33Billing provider infoOREGON ONCOLOGY SPECIALISTS, LLP
SALEM, OR 97301
SALEM, OR 97301
33aNPI1013953025assigned 06/20/2006
33bProvider typeInfectious Disease Physician
28Total paid$3.50M
24GClaims136,948
24DCodes billed35
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Infectious Disease Physician providers in Oregon
Rank by total paid#1 of 6
Median peer was paid$38K
This provider vs. median92×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 16,859 | $431K | |
| 2019 | 19,987 | $519K | |
| 2020 | 19,141 | $449K | |
| 2021 | 18,505 | $412K | |
| 2022 | 21,519 | $490K | |
| 2023 | 20,358 | $539K | |
| 2024incomplete | 20,579 | $664K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 36% | 17,590 | 15,202 | $1.27M |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 24% | 7,322 | 4,302 | $839K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 16% | 10,893 | 9,432 | $572K |
| 80053 | Comprehensive metabolic panel | 4.3% | 28,015 | 19,677 | $152K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.9% | 33,537 | 23,172 | $136K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 3.5% | 971 | 909 | $121K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 2.2% | 789 | 703 | $77K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.1% | 1,504 | 979 | $74K |
| 96367 | 2.1% | 2,466 | 1,441 | $72K | |
| 36415 | Collection of venous blood by venipuncture | 1.5% | 21,974 | 17,069 | $51K |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 1.1% | 961 | 460 | $38K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,737 | 1,768 | $30K |
23 more codes
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 714 | $30K |
| 82728 | <1% | 1,265 | $10K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 61 | $6K |
| 99205 | Prolong outpt/office vis | <1% | 27 | $5K |
| 99223 | Prolong inpt eval add15 m | <1% | 50 | $4K |
| 85651 | <1% | 1,451 | $4K | |
| J2469 | Injection, palonosetron hcl, 25 mcg | <1% | 252 | $3K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,880 | $3K |
| J1453 | Injection, fosaprepitant, 1 mg | <1% | 108 | $2K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 90 | $2K |
| 86140 | <1% | 498 | $2K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 17 | $1K |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 18 | $1K |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 38 | $1K |
| 83615 | <1% | 321 | $935.48 | |
| 96417 | <1% | 22 | $621.31 | |
| 96415 | <1% | 21 | $605.69 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 52 | $502.09 |
| 99490 | Ccm add 20min | <1% | 64 | $282.34 |
| 83550 | <1% | 41 | $229.40 | |
| 83735 | <1% | 55 | $170.38 | |
| 83540 | <1% | 41 | $169.97 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 103 | $72.93 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPIERCE, WILLIAM (PARTNER)
| Provider | Location | Paid |
|---|---|---|
| Yaneth, LLC | Lapeer, MI | $126K |
| Oregon Oncology Specialists, LLP | Mcminnville, OR | $1K |
| William J. Pierce,m.D.,P.C. | Merrillville, IN | $163.03 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.